Abstract:The identification of metastasis "seeds", isolated tumor cells (ITCs), is of paramount importance for the prognosis and tailored treatment of metastatic diseases. The conventional approach to clinical ITCs diagnosis through invasive biopsies is encumbered by the inherent risks of overdiagnosis and overtreatment. This underscores the pressing need for non‐invasive ITCs detection methods that provide histopathological‐level insights. Recent advancements in ultra‐high‐field (UHF) magnetic resonance imaging (MRI) have ignited hope for the revelation of minute lesions, including the elusive ITCs. Nevertheless, currently available MRI contrast agents are susceptible to magnetization‐induced strong T2‐decaying effects under UHF conditions, which compromises T1 MRI capability and further impedes the precise imaging of small lesions. Herein, we report a structural defect‐enabled magnetic neutrality nanoprobe (MNN) distinguished by its paramagnetic properties featuring an exceptionally low magnetic susceptibility through atomic modulation, rendering it almost non‐magnetic. This unique characteristic effectively mitigates T2‐decaying effect while concurrently enhancing UHF T1 contrast. Under 9 T MRI, the MNN demonstrates an unprecedentedly low r2/r1 value (∼1.06), enabling non‐invasive visualization of ITCs with an exceptional detection threshold of ∼0.16 mm. These high‐performance MNNs unveil the domain of hitherto undetectable minute lesions, representing a significant advancement in UHF‐MRI for diagnostic purposes and fostering comprehensive metastasis research. This article is protected by copyright. All rights reserved

Structural Defect‐Enabled Magnetic Neutrality Nanoprobes for Ultra‐High‐Field Magnetic Resonance Imaging of Isolated Tumor Cells In Vivo

Artificially Engineered Antiferromagnetic Nanoprobes for Ultra-Sensitive Histopathological Level Magnetic Resonance Imaging.

A Bioinspired Nanoprobe with Multilevel Responsive T1‐Weighted MR Signal‐Amplification Illuminates Ultrasmall Metastases

Magnetic resonance molecular imaging of metastatic breast cancer by targeting extradomain-B fibronectin in the tumor microenvironment.

Ligand‐Mediated Magnetism‐Conversion Nanoprobes for Activatable Ultra‐High Field Magnetic Resonance Imaging

Structural and Molecular Fusion MRI Nanoprobe for Differential Diagnosis of Malignant Tumors and Follow-Up Chemodynamic Therapy.

A Specific "Switch-On" Type Magnetic Resonance Nanoprobe With Distance-Dominate Property For High-Resolution Imaging Of Tumors

Fabrication of magnetic nanoprobes for ultrahigh-field magnetic resonance imaging

Fabrication of Magnetic Nanoprobes for Ultrahigh-Field Magnetic Resonance Imaging.

Magnetic Field-Optimized Paramagnetic Nanoprobe for T2/T1 Switchable Histopathological-Level MRI

Time-Dependent T-1-T-2 Switchable Magnetic Resonance Imaging Realized by C(rgdyk) Modified Ultrasmall Fe3O4 Nanoprobes

Biomineralization Synthesis of HoMn Nanoparticles for Ultrahigh-Field-Tailored and T1-T2 Dual-Mode MRI-Guided Cancer Theranostics

A Protein-Corona-Free T-1-T-2 Dual-Modal Contrast Agent for Accurate Imaging of Lymphatic Tumor Metastasis

Bimagnetic Core/Shell Nanoprobes with Tunable Exchange Coupling for High Resolution and Sensitive Magnetic Particle Imaging

Magnetic Resonance Diagnosis of Early Triple-Negative Breast Cancer Based on the Ionic Covalent Organic Framework with High Relaxivity and Long Retention Time.

Mono-dispersed high magnetic resonance sensitive magnetite nanocluster probe for detection of nascent tumors by magnetic resonance molecular imaging.

Improving Sensitivity of Magnetic Resonance Imaging by Using a Dual-Targeted Magnetic Iron Oxide Nanoprobe.

Artificially Engineered Nanoprobes for Ultrasensitive Magnetic Resonance Imaging.

Small is Smarter: Nano MRI Contrast Agents – Advantages and Recent Achievements

DNA-Mediated Magnetic-Dimer Assembly for Fault-Free Ultra-High-Field Magnetic Resonance Imaging of Tumors

Magnetic Field-Optimized Paramagnetic Nanoprobe for T 2 / T 1 Switchable Histopathological-Level MRI